CINA-CSpine is designed to assist in detecting and triaging cervical spine fractures from CT images. Credit: Chinnapong/Shutterstock.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Avicenna.AI’s CINA-CSpine tool.

This AI solution is developed to automatically detect and prioritise life-threatening conditions, assess them for severity, and seamlessly notify clinicians.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

CINA-CSpine is engineered to aid in the detection and triage of cervical spine fractures from computed tomography (CT) images.

These fractures, often resulting from traumatic injuries, can lead to severe neurological damage or paralysis if not treated promptly. The tool’s purpose is to enhance outcomes and reduce long-term complications by accelerating the detection process and facilitating timely treatment.

The AI tool works by flagging suspected positive findings that are compatible with acute cervical spine fractures, thereby alerting radiologists with their existing systems.

See Also:

Avicenna.AI co-founder and CEO Cyril Di Grandi said: “Cervical spine fractures are serious injuries that require prompt and appropriate medical attention, especially if the spinal cord is involved, so accurate diagnosis is essential.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“With CINA-CSpine, we aim to help reduce the delay between scan and interpretation, which is critical in the treatment of this condition.”

Avicenna.AI’s CINA-CSpine was validated using more than 300 non-contrast CT scans from the US and Europe, taken from 36 different scanner models across five vendors.

It demonstrated overall sensitivity and specificity of 90.3% and 91.9%, respectively.

In June 2024, Avicenna.AI received 510(k) clearance from the FDA for its AI tool CINA-VCF, which is designed to detect vertical compression fractures.

Avicenna.AI’s portfolio features seven other AI tools, including solutions for the prevention and detection of intracranial haemorrhage, pulmonary embolism, vertical compression fractures, and the ASPECT Score for stroke severity quantification.